Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioadaptives (BDPT) Inventory Average (2016 - 2025)

Bioadaptives' Inventory Average history spans 7 years, with the latest figure at $44467.0 for Q4 2025.

  • On a quarterly basis, Inventory Average changed N/A to $44467.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $44467.0, a N/A change, with the full-year FY2025 number at $31910.5, up 85.55% from a year prior.
  • Inventory Average hit $44467.0 in Q4 2025 for Bioadaptives, up from $41901.0 in the prior quarter.
  • Over the last five years, Inventory Average for BDPT hit a ceiling of $44467.0 in Q4 2025 and a floor of $4161.0 in Q1 2022.
  • Historically, Inventory Average has averaged $15942.8 across 5 years, with a median of $10707.2 in 2021.
  • Biggest five-year swings in Inventory Average: tumbled 68.12% in 2022 and later soared 226.22% in 2025.
  • Tracing BDPT's Inventory Average over 5 years: stood at $7175.5 in 2021, then grew by 17.6% to $8438.5 in 2022, then skyrocketed by 33.5% to $11265.5 in 2023, then rose by 9.06% to $12286.0 in 2024, then surged by 261.93% to $44467.0 in 2025.
  • Business Quant data shows Inventory Average for BDPT at $44467.0 in Q4 2025, $41901.0 in Q3 2025, and $40079.0 in Q2 2025.